Longeveron Inc. (LGVN)
NASDAQ: LGVN · IEX Real-Time Price · USD
1.88
-0.07 (-3.59%)
At close: Nov 27, 2023, 4:00 PM
1.98
+0.10 (5.32%)
After-hours: Nov 27, 2023, 4:53 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $44.65 million as of November 28, 2023. Its market cap has decreased by -50.61% in one year.
Market Cap
44.65M
Enterprise Value
42.90M
1-Year Change
-50.61%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $44.65M, a decrease of -74.11%. That is a compound annual growth rate of -38.49%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 24, 2023 | 46.30M | 2.66% |
Nov 22, 2023 | 45.10M | 0.45% |
Nov 21, 2023 | 44.90M | -1.54% |
Nov 20, 2023 | 45.60M | 1.11% |
Nov 17, 2023 | 45.10M | 4.40% |
Nov 16, 2023 | 43.20M | -5.26% |
Nov 15, 2023 | 45.60M | 9.62% |
Nov 14, 2023 | 41.60M | -2.80% |
Nov 13, 2023 | 42.80M | -0.93% |
Nov 10, 2023 | 43.20M | -5.68% |
Nov 9, 2023 | 45.80M | 9.83% |
Nov 8, 2023 | 41.70M | 1.46% |
Nov 7, 2023 | 41.10M | 0.49% |
Nov 6, 2023 | 40.90M | -1.45% |
Nov 3, 2023 | 41.50M | -3.94% |
Nov 2, 2023 | 43.20M | -0.92% |
Nov 1, 2023 | 43.60M | 4.56% |
Oct 31, 2023 | 41.70M | 1.96% |
Oct 30, 2023 | 40.90M | 3.81% |
Oct 27, 2023 | 39.40M | -1.99% |
Oct 26, 2023 | 40.20M | -2.66% |
Oct 25, 2023 | 41.30M | -0.96% |
Oct 24, 2023 | 41.70M | 0.97% |
Oct 23, 2023 | 41.30M | - |
Oct 20, 2023 | 41.30M | 0.98% |
View and export this data all the way back to 2021.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Vivani Medical | 48.04M |
FibroGen | 47.69M |
Assembly Biosciences | 47.24M |
Cue Health | 47.16M |
SAB Biotherapeutics | 47.09M |
Matinas BioPharma Holdings | 45.63M |
Aeglea BioTherapeutics | 44.70M |
ReWalk Robotics | 44.69M |